Screening Adults With Obesity to Reduce Heart Failure Events

Launched by FRANCISCUS GASTHUIS · Nov 13, 2023

Keywords

ClinConnect Summary

This clinical trial is focused on finding out if checking for early signs of heart failure (HF) in adults with obesity can help improve their health outcomes. Heart failure is a serious condition that can happen more often in people who are obese, but it often goes unnoticed because symptoms can be mistaken for obesity-related issues. By screening adults aged 45 and older, who have a body mass index (BMI) of 30 or more and do not have known heart disease, the researchers hope to identify risk factors or early signs of heart failure. This could lead to earlier treatment and better quality of life for those affected.

If you are interested in participating, you will need to be at least 45 years old and have a BMI of 30 or higher. Participants will undergo several tests, including a physical exam, heart monitoring with an ECG, blood tests, and an ultrasound of the heart, to check for any problems related to heart function. This study is currently recruiting participants and aims to help us understand how early screening might prevent heart failure in individuals with obesity.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age ≥45 year
• • BMI ≥30 kg/m2
• • Written informed consent.
• Exclusion Criteria:
• • Known cardiac disease (determined by asking the patient and by assessment of the available patient files).
• • Treatment with weight-reducing medication.